Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Marty

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Seminars in Oncology|October 31, 2002
Metastatic melanoma: chemotherapyEmilio Bajetta, Michele Del Vecchio, Chantal Bernard-Marty, et al.
Science Advances|May 7, 2016
The presence of clathrates in comet 67P/Churyumov-GerasimenkoAdrienn Luspay-Kuti, Olivier Mousis, Myrtha Hässig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sitesD Gancberg, A Di Leo, F Cardoso, et al.
Clinical Breast Cancer|December 9, 2004
Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancerFatima Cardoso, Marianne Paesmans, Denis Larsimont, et al.
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant chemotherapy in 2005: standards and beyondM J Piccart, D de Valeriola, L Dal Lago, et al.
Critical Reviews in Oncology/Hematology|March 4, 2008
A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristicsV Durbecq, L Ameye, I Veys, et al.
Clinical Breast Cancer|January 21, 2003
Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot studyChantal Bernard-Marty, Isabelle Treilleux, Charles Dumontet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2010
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paperM Aapro, C Bernard-Marty, E G C Brain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxelCarlos M Galmarini, Isabelle Treilleux, Fatima Cardoso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patientsC Bernard-Marty, M Mano, M Paesmans, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Seminars in Oncology|October 31, 2002
Metastatic melanoma: chemotherapyEmilio Bajetta, Michele Del Vecchio, Chantal Bernard-Marty, et al.
Science Advances|May 7, 2016
The presence of clathrates in comet 67P/Churyumov-GerasimenkoAdrienn Luspay-Kuti, Olivier Mousis, Myrtha Hässig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sitesD Gancberg, A Di Leo, F Cardoso, et al.
Clinical Breast Cancer|December 9, 2004
Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancerFatima Cardoso, Marianne Paesmans, Denis Larsimont, et al.
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant chemotherapy in 2005: standards and beyondM J Piccart, D de Valeriola, L Dal Lago, et al.
Critical Reviews in Oncology/Hematology|March 4, 2008
A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristicsV Durbecq, L Ameye, I Veys, et al.
Clinical Breast Cancer|January 21, 2003
Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot studyChantal Bernard-Marty, Isabelle Treilleux, Charles Dumontet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2010
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paperM Aapro, C Bernard-Marty, E G C Brain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxelCarlos M Galmarini, Isabelle Treilleux, Fatima Cardoso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patientsC Bernard-Marty, M Mano, M Paesmans, et al.
Pageof 7